DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kohn A, Prantera C, Pera A. et al
Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.
Digestive and Liver Disease Official: Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2002; 34: 626-630
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.